logo
Share SHARE
FONT-SIZE Plus   Neg

Mundipharma Presents Positive Findings From Flutiform Study - Quick Facts

Vectura Group plc (VEC.L) announced that the its partner, the Mundipharma network, presented positive findings from largest ever flutiform study and supportive new data on flutiform k-haler at ERS 2017. The flutiform study, or the AffIRM study, confirmed effectiveness and tolerability in real-world clinical practice. Safety profile of flutiform pMDI in practice was consistent with that demonstrated in clinical trials.

James Ward-Lilley, CEO of Vectura, said: "AffIRM flutiform study provides further evidence this is an effective and differentiated treatment for asthma patients."

Mundipharma reported that the new data on flutiform k-haler (125/5 microgram), the company's breath-triggered aerosol inhaler currently under development, demonstrated efficient drug delivery characteristics. Flutiform k-haler achieved high levels of lung deposition of over 44% of delivered dose. Pharmacokinetic studies show efficacy and safety profile of new flutiform k-haler device would be comparable to flutiform pMDI device.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of thyssenKrupp AG were gaining around 2 percent in the morning trading in Germany after the steel giant Thursday said it expects clearly positive net income and significantly higher adjusted EBIT, a key earnings metric, in fiscal 2018. This was after reporting higher adjusted EBIT, sales and order intake in its fiscal 2017, despite a net loss due to charges. Senator Lisa Murkowski, R-Alaska, has expressed support for repealing Obamacare's individual mandate, a key provision Senate Republicans are hoping to use to offset the cost of their tax reform bill. The Congressional Budget Office estimates repealing the requirement that nearly all Americans purchase... Automotive startup Divergent 3D said that a Chinese-led investment syndicate has agreed to commit up to $107 million in financing through a new investment round. Hong Kong-based investment holding company, O Luxe Holdings Limited, led the investment group, which includes Horizons Ventures, Shanghai Alliance Investment Limited and Altran Technologies.
comments powered by Disqus
Follow RTT